Почетна › Рак на дојка › Калифорнија

Клинички испитувања за Рак на дојка во Калифорнија

179 студии за Рак на дојка бараат учесници на локации во Калифорнија.

Градови во Калифорнија

Официјален текст на студијата (англиски)

The Vanguard Study: Testing a New Way to Screen for Cancer

Kaiser Permanente-Division of Research, Pleasanton

Се регрутираДобредојдени се здрави волонтери

Возраст од 45 до 75 · Сите полови · Ажурирано 5.10.2026 · NCT06995898

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site, Los Angeles
Research Site, San Francisco

Се регрутираФаза 1/2

Возраст од 18 до 130 · Сите полови · Ажурирано 5.10.2026 · NCT05417594

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Beverly Hills Cancer Center, Beverly Hills
City of Hope National Medical Center, Duarte
Cedars-Sinai Medical Center, Los Angeles
и уште 5

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06982521

A Study of PHST001 in Advanced Solid Tumors

Precision NextGen Oncology & Research Center, Beverly Hills
USC Norris Comprehensive Cancer Center, Los Angeles
Stanford University School of Medicine, Palo Alto

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06840886

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of San Diego Moores Cancer Center, La Jolla
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles

Се регрутираФаза 1/2

Возраст 12 и постари · Сите полови · Ажурирано 2.10.2026 · NCT04585750

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

City of Hope - Duarte Cancer Center, Duarte

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06760819

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Onco Inst of Hope and Innovation, Cerritos
City of Hope National Medical, Duarte
Providence Medical Foundation, Fullerton
и уште 7

Се регрутираФаза 3

Возраст од 18 до 100 · Сите полови · Ажурирано 2.10.2026 · NCT05827081

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
и уште 10

Се регрутира

Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
и уште 20

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери

Возраст од 40 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT05334069

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Oncology Institute, Long Beach
Cancer & Blood Research Center, Los Alamitos

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT07102381

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06172478

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Stanford Medicine Cancer Center, Stanford

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT07701941

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

City of Hope Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine
City of Hope at Long Beach Elm, Long Beach
и уште 1

Се регрутираФаза 2

Возраст 70 и постари · Сите полови · Ажурирано 1.10.2026 · NCT04305834

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Beverly Hills Cancer Center, Beverly Hills
MemorialCare Orange Coast Medical Center, Fountain Valley
City of Hope at Orange County Lennar Foundation Cancer Center, Irvine
и уште 3

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06369285

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

City of Hope Comprehensive Cancer Center, Duarte
University of California Los Angeles, Los Angeles
University of California San Diego Moores Cancer Center, San Diego

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06625775

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

The Oncology Institute of Hope and Innovation, Cerritos
Ellison Medical Institute, Los Angeles
Valkyrie Clinical Trials, Los Angeles
и уште 3

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT06324357

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

California Protons Cancer Therapy Center, San Diego

Се регрутираФаза 2

Возраст 50 и постари · Жени · Ажурирано 29.9.2026 · NCT01766297

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Duarte
Research Site, Los Angeles
Research Site, Newport Beach
и уште 1

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT05877599

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

California Protons Cancer Therapy Center, San Diego

Се регрутираФаза 3

Возраст 19 и постари · Жени · Ажурирано 29.9.2026 · NCT05856773

IKS014 in Advanced Solid Tumors That Express HER2

Hoag Memorial Hospital Presbyterian, Newport Beach

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT05872295

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Los Angeles Hematology Oncology Medical Group ( Site 0026), Los Angeles
Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07060807

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Providence Medical Foundation-Oncology ( Site 0020), Fullerton

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06312176

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Fountain Valley
Research Site, Glendale
Research Site, Sacramento

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06103864

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Providence Medical Foundation, Eureka
Providence Medical Foundation, Santa Rosa

Се регрутираФаза 3

Возраст 60 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06377852

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

City of Hope, Duarte
UC San Diego Moores Cancer Center, La Jolla
UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07007559

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Roy and Patricia Disney Family Cancer Center ( Site 0055), Burbank
Community Cancer Institute ( Site 0100), Clovis
Providence Medical Foundation ( Site 0080), Fullerton
и уште 4

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06966700

A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

Los Angeles Cancer Network, Los Angeles
Community Clinical Trials, Orange

Се регрутираФаза 2

Возраст 18 и постари · Жени · Ажурирано 25.9.2026 · NCT07054190

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, Santa Monica

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT07229313

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Marin Cancer Care, Greenbrae
Loma Linda University, Loma Linda
Cancer and Blood Research Center, Los Alamitos
и уште 3

Се регрутира

Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07214532

A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills

Се регрутираФаза 1

Возраст од 18 до 80 · Жени · Ажурирано 23.9.2026 · NCT07401381

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Beverly Hills
Clinical Trial Site, La Jolla
Clinical Trial Site, Los Alamitos
и уште 8

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07085767

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Hoag Memorial Hospital Presbyterian, Newport Beach
Stanford University Medical Center, Stanford

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Community Cancer Institute, Clovis
City of Hope, Duarte
Epic Care - Emeryville, Emeryville
и уште 19

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

City of Hope, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Irvine
USC/Norris Comprehensive Cancer Center, Los Angeles
и уште 1

Се регрутираФаза 2

Возраст 18 и постари · Жени · Ажурирано 22.9.2026 · NCT07287098

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

University of California Irvine, Irvine
University of California Los Angeles, Los Angeles
University of California Davis, Sacramento
и уште 2

Се регрутираДобредојдени се здрави волонтери

Возраст од 30 до 74 · Жени · Ажурирано 21.9.2026 · NCT02620852

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Disney Family Cancer Center, Burbank
City of Hope, Corona
City of Hope Comprehensive Cancer Center, Duarte
и уште 2

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT05894239

Pulsed Electric Field Ablation for Metastatic Breast Cancer

University of California San Francisco, San Francisco

Се регрутира

Возраст 18 и постари · Сите полови · Ажурирано 18.9.2026 · NCT07487844

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Beverly Hills Cancer Center, Beverly Hills
Hoag Memorial Hospital Presbyterian, Newport Beach

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT06827236

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

University Of California - San Diego Moores Cancer Center, La Jolla
Cancer and Blood Specialty Clinic (CBSC), Los Alamitos
Cedar Sinai - Samuel Oschin Cancer Center, Los Angeles
и уште 4

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT07173751

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.